Susan Rienow

age:

44 years

appointments:

14 active

4 prior

primary industry:

Scientific research and development

about Susan

Since 2018, Mrs Rienow has been a director of 18 companies, the current directorship have a combined turnover of approximately £4b.

Combined Valuation

£10.1b

Combined Turnover

£4b

active directorships over time

company
turnover
valuation
start
end
status
role
pfizer limited£3.1b£5.3bFeb 2022-OpenDirector
pfizer development services (uk) limited£150.6m£1.1bFeb 2022-OpenDirector
pfizer development services (uk) limited£150.6m£1.1bFeb 2022-OpenDirector
pharmacia limited£33m£643.4mFeb 2022-OpenDirector
pharmacia limited£33m£643.4mFeb 2022-OpenDirector
pfizer r&d uk limited£262.4m£609.7mFeb 2022-OpenDirector
pfizer r&d uk limited£262.4m£609.7mFeb 2022-OpenDirector
hospira uk limited£0£50.3mFeb 2022-OpenDirector
global blood therapeutics uk limited£1.7m£35.4mApr 2023-OpenDirector
seagen u.k. ltd.£7.5m£15.5mDec 2023-OpenDirector
pfizer consumer healthcare£0£8.1mFeb 2022-OpenDirector
pfizer consumer healthcare£0£8.1mFeb 2022-OpenDirector
neusentis limited£0£0Feb 2022-OpenDirector
neusentis limited£0£0Feb 2022-OpenDirector